These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2713563)

  • 1. Vinca alkaloids.
    Freireich EJ
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():56. PubMed ID: 2713563
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of F-Leurosin therapy].
    Farkas E; Eckhardt S
    Orv Hetil; 1977 Jun; 118(24):1403-7. PubMed ID: 865824
    [No Abstract]   [Full Text] [Related]  

  • 3. Vinca alkaloids.
    Chabner BA; Horwitz SB; Clendennin NJ; Purvis JD
    Cancer Chemother Biol Response Modif; 1991; 12():67-73. PubMed ID: 1681845
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of vinca alkaloids.
    Rahmani R; Zhou XJ
    Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer chemotherapy: What drugs are available.
    Carter SK; Kershner LM
    Med Times; 1976 Feb; 104(2):154-62. PubMed ID: 1246181
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I trial of vinzolidine.
    Budman DR; Schulman P; Marks M; Vinciguerra V; Weiselberg L; Kreis W; Degnan TJ
    Cancer Treat Rep; 1984; 68(7-8):979-82. PubMed ID: 6744350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery systems and combination therapy by using vinca alkaloids.
    Lee CT; Huang YW; Yang CH; Huang KS
    Curr Top Med Chem; 2015; 15(15):1491-500. PubMed ID: 25877096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical uses of macrophage inhibitors.
    Ahn YS; Harrington WJ
    Adv Intern Med; 1980; 25():453-73. PubMed ID: 6987849
    [No Abstract]   [Full Text] [Related]  

  • 9. KS1/4-DAVLB, a monoclonal antibody-vinca alkaloid conjugate for site-directed therapy of epithelial malignancies.
    Bumol TF; Baker AL; Andrews EL; DeHerdt SV; Briggs SL; Spearman ME; Apelgren LD
    Targeted Diagn Ther; 1988; 1():55-79. PubMed ID: 2979063
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of cytostatic drugs on blood platelets and lymphocytes in patients with neoplasms].
    Wand H; Rieche K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(5):800-9. PubMed ID: 4140820
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids: clinical developments.
    Brenner DE
    Curr Opin Oncol; 1990 Dec; 2(6):1115-8. PubMed ID: 2099842
    [No Abstract]   [Full Text] [Related]  

  • 12. The vinca alkaloids.
    O'Marcaigh AS; Betcher DL
    J Pediatr Oncol Nurs; 1995 Jul; 12(3):140-2. PubMed ID: 7646834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of vincamine treatment on cerebral arteriosclerotic vasculopathy].
    Saba GC; Locci P; Sgromo V; Gaspa F
    G Clin Med; 1976; 56(2):149-55. PubMed ID: 964523
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of resistance to anthracyclines and vinca alkaloids.
    Danø K; Skovsgaard T; Nissen NI; Friche E; Di Marco A
    Prog Clin Biol Res; 1983; 132C():231-46. PubMed ID: 6579564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and experimental evaluation of the use of eburnamonine in acute anc chronic cerebro-vascular insufficiency].
    Rampello L; Barbagallo G; Costanzo E; Sciacca A; Russo S
    Clin Ter; 1981 Feb; 96(4):371-81. PubMed ID: 7214860
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytostatic agents. 4: Cytostatically active vinca alkaloids].
    Sauer H
    Fortschr Med; 1991 Oct; 109(29):591. PubMed ID: 1783350
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of Cavinton on the pathological changes in ischemic brain changes starting as an acute disease].
    Bałuka-Horecka M
    Przegl Lek; 1982; 39(4):325-8. PubMed ID: 7100509
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of malignant lymphomas with vinca rosea alkaloids administered singly or in combination with other cytotoxic drugs.
    Klener P; Donner L
    Acta Univ Carol Med (Praha); 1974; 20(3-4):147-68. PubMed ID: 4455076
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prospects of using cavinton for treating Ménière's disease].
    Nikolaev MP; Konstantinova ZD; Mertsalova ON; Sheremet AS
    Vestn Otorinolaringol; 1980; (3):18-22. PubMed ID: 7385520
    [No Abstract]   [Full Text] [Related]  

  • 20. [The oncobiogram-- an indicator of chemotherapy in solid malignant human tumors].
    Schönfelder M
    Zentralbl Chir; 1974 Sep; 99(38):1198-208. PubMed ID: 4454780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.